UniQure Aiming To Be First With Hemophilia B Gene Therapy

Presenting 12 Month Data At ASH

 
• By Andrew McConaghie
uniQure
UniQure is headquartered in Amsterdam, the Netherlands • Source: UniQure

More from R&D

More from Scrip